Stocks
GlaxoSmithKline (GSK) Market cap US GAAP (year values)The current market cap of the company GlaxoSmithKline is 103 552 020 000 £. |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Market cap, £ | 70 612 920 000 | 0.00 | 0.00 | 68 942 070 000 | 49 665 260 000 | 103 552 020 000 | |||
| Changes by years, y/y, % | -4% | -100% | -28% | -7.5% | |||||
GlaxoSmithKline. Market cap, £
GlaxoSmithKline: рыночная капитализация + чистый долг (EV для GlaxoSmithKline), £
GlaxoSmithKline. Market cap, changes, %
GlaxoSmithKline (GSK) Market cap US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Market cap, £ | 79 184 560 000 | 78 009 600 000 | 87 053 720 000 | 49 272 940 000 | 111 014 685 000 | 103 552 020 000 | ||
| Changes by years, y/y, % | +4% | -29% | +40% | |||||
| Changes by quarters, q/q, % | +15% | -1% | +12% | -43% | +125% | |||
